Literature DB >> 18627196

Effect of transferrin as a ligand of pH-sensitive fusogenic liposome-lipoplex hybrid complexes.

Naoki Sakaguchi1, Chie Kojima, Atsushi Harada, Kazunori Koiwai, Nobuhiko Emi, Kenji Kono.   

Abstract

We previously developed potent nonviral vectors based on complexation of lipoplexes and pH-sensitive fusogenic liposomes, which achieve efficient transfection through membrane fusion with intracellular acidic compartments such as endosomes. Because transferrin receptor is known to be overexpressed in cancer cells, in this study, we investigated the effect of transferrin as a ligand for transfection of various cancer-derived cell lines mediated by the liposome-lipoplex hybrid complexes. Results showed that these hybrid complexes with transferrin exhibited higher transfection efficiency toward these cells than complexes without transferrin, but the extent of the transferrin-induced enhancement was dependent on the cell line. Conjugation of transferrin increased their transfection activity for HeLa and KB cells, although it only slightly enhanced transfection for HT1080, HepG2, and K562. Transferrin receptors in HT1080, HepG2, and K562 cells were internalized slowly, whereas those in HeLa and KB cells were internalized quickly and actively. These results indicate that transfection mediated by the ligand-attached hybrid complex does not correlate with the amount of transferrin receptor in the cell surface but correlate with the activity of internalization of transferrin receptor into the cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18627196     DOI: 10.1021/bc800126s

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  7 in total

1.  Iron transport in cancer cell culture suspensions measured by cell magnetophoresis.

Authors:  Xiaoxia Jin; Jeffrey J Chalmers; Maciej Zborowski
Journal:  Anal Chem       Date:  2012-04-26       Impact factor: 6.986

Review 2.  Targeted Liposomes: A Nonviral Gene Delivery System for Cancer Therapy.

Authors:  Marcela Tavares Luiz; Jessyca Aparecida Paes Dutra; Larissa Bueno Tofani; Jennifer Thayanne Cavalcante de Araújo; Leonardo Delello Di Filippo; Juliana Maldonado Marchetti; Marlus Chorilli
Journal:  Pharmaceutics       Date:  2022-04-08       Impact factor: 6.525

Review 3.  Current trends in the use of liposomes for tumor targeting.

Authors:  Pranali P Deshpande; Swati Biswas; Vladimir P Torchilin
Journal:  Nanomedicine (Lond)       Date:  2013-09       Impact factor: 5.307

4.  Novel PAMAM-PEG-Peptide Conjugates for siRNA Delivery Targeted to the Transferrin and Epidermal Growth Factor Receptors.

Authors:  Koldo Urbiola; Laura Blanco-Fernández; Manfred Ogris; Wolfgang Rödl; Ernst Wagner; Conchita Tros de Ilarduya
Journal:  J Pers Med       Date:  2018-01-09

Review 5.  Advances in delivery methods of Arthrospira platensis (spirulina) for enhanced therapeutic outcomes.

Authors:  Omar Ashraf ElFar; Nashiru Billa; Hooi Ren Lim; Kit Wayne Chew; Wai Yan Cheah; Heli Siti Halimatul Munawaroh; Deepanraj Balakrishnan; Pau Loke Show
Journal:  Bioengineered       Date:  2022-06       Impact factor: 6.832

6.  A Novel Isoquinoline Derivative Anticancer Agent and Its Targeted Delivery to Tumor Cells Using Transferrin-Conjugated Liposomes.

Authors:  Xuewei Yang; Shuang Yang; Hongyu Chai; Zhaogang Yang; Robert J Lee; Weiwei Liao; Lesheng Teng
Journal:  PLoS One       Date:  2015-08-26       Impact factor: 3.240

Review 7.  Non-viral Delivery of Nucleic Acids: Insight Into Mechanisms of Overcoming Intracellular Barriers.

Authors:  Mikhail Durymanov; Joshua Reineke
Journal:  Front Pharmacol       Date:  2018-08-21       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.